Seven Chinesemade COVID vaccines enter phase clinical trials official
2021-01-31 15:15
A staff member displays a sample of the COVID inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group Co Ltd Sinopharm in Beijing, capital of China, April , . PhotoXinhua    BEIJING  A total of seven Chinesemade COVID vaccines have entered phase clinical trials, according to an official with the Ministry of Science and Technology MOST. China now has  selfdeveloped COVID vaccines undergoing clinical trials, said Wu Yuanbin, directorgeneral of science and technology for social development with MOST, at a recent conference on hematology. An inactivated vaccine developed by Beijing Biological Products Institute Co Ltd under the China National Biotec Group CNBG, affiliated with Sinopharm, was last month the first to receive conditional market approval from the National Medical Products Administration. The interim results of its phase clinical trials show . percent efficacy against COVID.